Schellekens_BLongum_Obesity_Stress_EBIOM_103176 (003)

Atlantia is a world-class provider of human clinical studies. For over a decade we have delivered clinical results to our many clients around the world, on time and on budget. We strive to offer the highest quality science while maintaining a cost-conscious approach to maximize the value proposition for each of our clients.


Bifidobacterium longum counters the effects of obesity: Partial successful translation from rodent to human
1

Keywords
1

Abstract
1

Background
1

Methods
1

Findings
1

Interpretation
1

Funding
1

Ev­i­dence be­fore this study
2

Added value of this study
2

Im­pli­ca­tions of avail­able ev­i­dence
2

Introduction
2

Methods – animal study
2

Animals, diets and ethical approval
2

In vivo probiotic administration
3

In vivo glucose tolerance test
3

Murine tissue sampling
3

Murine biochemical analysis
3

Murine RNA isolation and quantitative real-time PCR
3

Methods – human intervention study
3

Human intervention study outline
3

Inclusion and exclusion criteria
3

Study setting and ethical approval
4

Randomisation and blinding
4

Study recruitment
4

Product formulation and dosage
4

Collection and analysis of blood samples
5

Collection and analysis of cortisol awakening response samples
5

Methods – murine and human microbiota
5

Murine and human microbiota sequencing
5

Faecal SCFA quantification
6

Questionnaires
6

Statistical analysis
6

Results
6

B. longum APC1472 decreases body weight gain and fat depots accumulation in obese mice
6

B. longum APC1472 administration improves glucose tolerance, circulating levels of leptin and corticosterone in obese mice
7

B. longum APC1472 induces changes of hypothalamic neuropeptide expression in mice
7

Human intervention study population
8

Adverse events
8

B. longum APC1472 does not affect BMI and W/H ratio in humans
8

B. longum APC1472 improves fasting glucose levels independent of other blood markers of energy metabolism and satiety in humans
8

B. longum APC1472 does not influence human lipid and inflammatory profiles in humans
8

B. longum APC1472 does not affect satiety, mood, perceived stress and cortisol awakening response in humans
9

B. longum APC1472 improves fasting glucose levels, active ghrelin and cortisol awakening response in obese individuals
9

B. longum APC1472 does not induce major rearrangements on the microbiota composition but increases the abundance of Bifidobacterium
9

Discussion
10

Data sharing
14

Disclosure
14

Contributions
14

Uncited references
14

Acknowledgements
14

Supplementary materials
14

Footnotes
14

Article Footnotes
14

References
14

atlantiaclinicaltrials.com

Powered by